Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, 7SL, cytoplasmic 870, pseudogene (RN7SL870P) is a human genomic sequence classified as a pseudogene corresponding to 7SL RNA, which is a component of the signal recognition particle (SRP)[4][5][6]. A pseudogene resembles its parental gene but has lost the ability to encode a functional, expressed product; most 7SL-related sequences in the human genome are pseudogenes that result from retrotransposition events of 7SL RNA back into the genomic DNA[1][5][6]. These pseudogenes are typically **truncated copies** of the original 7SL RNA, lacking function and not contributing to the canonical SRP complex or protein targeting pathways[5][6]. There is no evidence that RN7SL870P is expressed or has any biological or therapeutic relevance, and it is **not considered a drug target**[4][5][6]. It is primarily of genomic interest, providing insight into the evolution of non-coding RNA elements in the human genome.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 7SL, cytoplasmic 870, pseudogene (RN7SL870P).